N | Sensitivity (95% CI) | Specificity (95% CI) | LR positive (95% CI) | LR negative (95% CI) | Positive PV (95% CI) | Negative PV (95% CI) | |
---|---|---|---|---|---|---|---|
Urine LAM | |||||||
All participants | 92 | 25.0% (16.6-35.1) | 91.2% (87.0-94.4) | 2.84 (1.67-4.84) | 0.82 (0.73-0.93) | 51.1% (35.8-66.3) | 76.8% (71.5-81.5) |
CD4 ≥ 100 cells/mm3 | 35 | 22.8% (10.4-40.1) | 92.7% (87.3-96.3) | 3.14 (1.36-7.22) | 0.83 (0.69-1.00) | 42.1% (20.3-66.5) | 83.8% (77.4-89.1) |
CD4 < 100 cells/mm3 | 47 | 27.7% (15.6-42.6) | 84.8% (71.1-93.7) | 1.82 (0.80-4.14) | 0.85 (0.69-1.06) | 65.0% (40.8-84.6) | 53.4% (41.4-65.2) |